SIRT1 elevation has been associated with tumor progression and a worse prognosis in several cancer types (e.g., bladder, breast, hepatocellular carcinoma, gastric, and pancreatic cancer) [48–53]. The gene discussed is SIRT1; the disease is hepatocellular carcinoma.